PATENT CLAIM ANALYSIS

Application Number: 16019636
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["435", "235100"]

Abstract:
The invention in some aspects relates to recombinant adeno-associated viruses having distinct tissue targeting capabilities. In some aspects, the invention relates to gene transfer methods using the recombinant adeno-associate viruses. In some aspects, the invention relates to isolated AAV capsid proteins and isolated nucleic acids encoding the same.

Claim (Index 59):
The rAAV of  claim 58 , wherein the coding sequence encodes a therapeutic protein.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 94.0
- Lexical Diversity: 1.60606
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13322164', '15007559', '14246560', '15520977', '15120294']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7617362836471626
- 35 USC 102 Novelty (BERT): 0.6697435314164913
- Combined Prediction Score: 0.7525370084240955
- Mean Citation Score: 617.305788
- Max Citation Score: 731.7288
- Similarity Product: 516.7365882050514

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test